Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs indomethacin in moderate to severe acute gouty arthritis
2007-005912-23Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of celecoxib and indomethacin in gout and acute gout flare (3 arms), sponsored by Pfizer. Primary endpoint: Change in patient's assessment of pain intensity in index joint from baseline to Day 2. Started Mar 2008; status: completed.
02
Drugs
celecoxibindomethacin
03
Conditions
goutacute gout flare
Beyond the preview
Go deeper on 2007-005912-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005912-23.